» Articles » PMID: 20534909

Alternative Splice Variants, a New Class of Protein Cancer Biomarker Candidates: Findings in Pancreatic Cancer and Breast Cancer with Systems Biology Implications

Overview
Journal Dis Markers
Publisher Wiley
Specialty Biochemistry
Date 2010 Jun 11
PMID 20534909
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

Alternative splicing plays an important role in protein diversity without increasing genome size. Earlier thought to be uncommon, splicing appears to affect the majority of genes. Alternative splice variants have been detected at the mRNA level in many diseases. We have designed and demonstrated a discovery pipeline for alternative splice variant (ASV) proteins from tandem MS/MS datasets. We created a modified ECgene database with entries from exhaustive three-frame translation of Ensembl transcripts and gene models from ECgene, with periodic updates. The human database has 14 million entries; the mouse database, 10 million entries. We match MS/MS findings against these potential translation products to identify and quantify known and novel ASVs. In this review, we summarize findings and systems biology implications of biomarker candidates from a mouse model of human pancreatic ductal adenocarcinoma [28] and a mouse model of human Her2/neu-induced breast cancer [27]. The same approach is being applied to human tumors, plasma, and cell line studies of other cancers.

Citing Articles

Decoding the role of aberrant RNA alternative splicing in hepatocellular carcinoma: a comprehensive review.

Sheng M, Zhang Y, Wang Y, Liu W, Wang X, Ke T J Cancer Res Clin Oncol. 2023; 149(19):17691-17708.

PMID: 37898981 DOI: 10.1007/s00432-023-05474-8.


Joint Secondary Transcriptomic Analysis of Non-Hodgkin's B-Cell Lymphomas Predicts Reliance on Pathways Associated with the Extracellular Matrix and Robust Diagnostic Biomarkers.

Rapier-Sharman N, Clancy J, Pickett B J Bioinform Syst Biol. 2023; 5(4):119-135.

PMID: 36873459 PMC: 9980876. DOI: 10.26502/jbsb.5107040.


The Impact of Biomarkers in Pancreatic Ductal Adenocarcinoma on Diagnosis, Surveillance and Therapy.

Sturm N, Ettrich T, Perkhofer L Cancers (Basel). 2022; 14(1).

PMID: 35008381 PMC: 8750069. DOI: 10.3390/cancers14010217.


A Roadmap Toward the Definition of Actionable Tumor-Specific Antigens.

Minati R, Perreault C, Thibault P Front Immunol. 2021; 11:583287.

PMID: 33424836 PMC: 7793940. DOI: 10.3389/fimmu.2020.583287.


Identification of novel alternative splicing biomarkers for breast cancer with LC/MS/MS and RNA-Seq.

Zhang F, Deng C, Wang M, Deng B, Barber R, Huang G BMC Bioinformatics. 2020; 21(Suppl 9):541.

PMID: 33272210 PMC: 7713335. DOI: 10.1186/s12859-020-03824-8.